B

Halozyme Therapeutics, Inc. HALO

NASDAQ
Recommendation
Dividend Power Score
Day's Range
$95.01$97.96
Latest Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
EPS (TTM)
My Lists My Alerts

09/30/2026 06/30/2026
Revenue 2.49% 27.68%
Total Other Revenue -- --
Total Revenue 2.49% 27.68%
Cost of Revenue 3.20% 1.94%
Gross Profit 2.29% 37.61%
SG&A Expenses 2.18% -1.53%
Depreciation & Amortization 0.00% 0.00%
Other Operating Expenses -- --
Total Operating Expenses 2.41% 0.60%
Operating Income 2.54% 55.90%
Income Before Tax 2.01% 57.99%
Income Tax Expenses -20.74% 81.61%
Earnings from Continuing Operations 7.45% 53.23%
Earnings from Discontinued Operations -- --
Extraordinary Item & Accounting Change -- --
Minority Interest in Earnings -- --
Net Income 7.45% 53.23%
EBIT 2.54% 55.90%
EBITDA 2.33% 47.98%
EPS Basic 10.74% 54.36%
Normalized Basic EPS 5.30% 59.19%
EPS Diluted 5.79% 55.74%
Normalized Diluted EPS 1.01% 60.18%
Average Basic Shares Outstanding -2.96% -0.74%
Average Diluted Shares Outstanding 1.15% -1.35%
Dividend Per Share -- --
Payout Ratio -- --